Ford revs up production of coronavirus ventilators

What does it take for a car manufacturer to make medical devices?

There are around 160,000 ventilators available for patients in the U.S. right now. In normal times, this would be more than enough for operating rooms and ICUs across the country.

However, these aren’t normal times. According to the American Hospital Association, as many as 960,000 patients with severe cases of COVID-19 will need a ventilator in order to breathe over the course of the pandemic.

To ramp up the supply of coronavirus ventilators, manufacturers of all types — particularly auto manufacturers like Tesla, GM, and Ford — are redirecting their manufacturing expertise to produce these life-saving machines.

But what does it take for a company that traditionally mass produces cars to suddenly turn around and make medical devices?

From F-150s to Coronavirus Ventilators

Ford, with help from GE and the United Auto Workers, has announced some ambitious plans.

“We said that we would deliver 50,000 ventilators in 100 days. And the administration has asked for 100,000 ventilators collectively across the industry in 100 days,” says Michael Levine, a member of Ford’s communications team.

“We can step in to provide half of that. And then once we ramp up, we can do a speed of 30,000 a month, and we could do it as long as there’s a need for that.”

Ford’s production goals through July. The car company plans to produce 50,000 coronavirus ventilators in 100 days. (Ford)(https://media.ford.com/content/fordmedia/fna/us/en/news/2020/03/30/ford-to-produce-50-000-ventilators-in-michigan-in-next-100-days.html)

But there’s a new challenge here. Ford isn’t making traditional ventilators. They’re making ventilators specific to the needs of COVID-19. The devices have to be quick to produce, cheap, and portable, so that they can be rushed to field hospitals if standard hospitals overflow. At the same time, they also have to pass FDA approval, which takes time, even if the approval process has been relaxed to help with production speed.

With those considerations in mind, Ford decided that the Model A-E ventilator, designed by GE and Airon, was the way to go. Compared to other ventilators, this model is lighter and smaller, doesn’t need a battery backup, and can function without electricity because it operates on air pressure alone. Since it’s designed for patients being transported in aircraft and ambulances, it’s optimized for use outside normal hospital settings.

The GE/Airon Model A-E ventilator next to an artificial lung. This ventilator is lighter and smaller than other models. (Ford)(https://www.conceptcarz.com/a36618/ford-ventilators-michigan.aspx)

Repurposing Manufacturing Equipment for a Cause

One of the biggest benefits of being a large auto manufacturer is that Ford can repurpose some of their manufacturing equipment into their new processes for ventilator production.

Adrian Price, Director of Global Core Engineering for Ford’s manufacturing team, notes that developing new processes early will ensure that they meet high-quality medical standards by the time those ventilators are shipped out.

“We have a team of engineers — industrial engineers, manufacturing engineers, facility engineers — who are all working together to take the assembly of that device and basically scale it from a point where it’s currently being made at a rate of about 10 a week to making it a rate of about 7,000 a week,” Price says.

While sheer scale and size means that Ford has the luxury of repurposing equipment in their plants, they still have to consider where they’re going to source their raw materials. This would be a challenge under any circumstances, but it’s especially difficult now that COVID-19 has disrupted global supply chains across countless industries.

To help open up the bottlenecks in supply chains, Ford has 3D scanned the Model A-E so they can break it down into all its component parts. They then turn to their purchasing and logistics teams to source those components at scale or, if they can’t buy them, they’ll replicate those parts themselves in their facility.

Once completed, Ford will ship the coronavirus ventilators to FEMA, who will then use their own distribution network to deliver devices to hot spots across the nation.

United Auto Workers Unite

With cities across the country on lockdown, who’s putting these devices together?

Thanks to help from the United Auto Workers union and a squadron of paid volunteers, Ford will have the manpower necessary to assemble coronavirus ventilators at their production facilities in Michigan. While they started with less than a dozen people, the aim is to ultimately employ upwards of 500 people assembling the machines.

“This kind of thing is really in the DNA of Ford Motor Company,” says Price, who notes that when the country is in need, Ford has a history of stepping up.

Ford will ship the ventilators to FEMA, who will use their own distribution network to deliver devices across the nation.

In the early 20th century, Ford made incubators for premature babies, and in the ’40s, it even made iron lungs during a polio epidemic. Both pieces of equipment were expensive, with not nearly enough supply for the people who needed them — but the company managed to produce the devices for a fraction of their usual cost.

That dedication to service in times of national crisis, according to Price, is a driving factor that leads people in the company to show up for essential work now, just as they did then.

*Editor’s Note: Ford is a sponsor of an upcoming Freethink series but had no input into this article*

Related
How to fight Covid with light
Some wavelengths of light in a range called far-UVC kill microbes in experiments and appear to be harmless to people.
UK study suggests single dose of monkeypox vaccine is 78% effective
A new analysis by the UK Health Security Agency has determined that one shot of a monkeypox vaccine is 78% effective at preventing infection.
When is the best time to exercise?
Though morning workouts may be optimal for circadian rhythms, afternoon exercise tends to be slightly more efficient.
Moderna to develop mRNA vaccines for Ebola
Moderna is reportedly nearing a deal with the DoD to develop mRNA vaccines for biological threats like Ebola
Yale’s new nasal vaccine can boost an mRNA shot
A nasal vaccine delivered as a booster to mRNA shots might offer better protection against COVID-19 and help stop the virus from spreading.
Up Next
coronavirus research
Subscribe to Freethink for more great stories